Nothing Special   »   [go: up one dir, main page]

GB9214184D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9214184D0
GB9214184D0 GB929214184A GB9214184A GB9214184D0 GB 9214184 D0 GB9214184 D0 GB 9214184D0 GB 929214184 A GB929214184 A GB 929214184A GB 9214184 A GB9214184 A GB 9214184A GB 9214184 D0 GB9214184 D0 GB 9214184D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929214184A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929214184A priority Critical patent/GB9214184D0/en
Publication of GB9214184D0 publication Critical patent/GB9214184D0/en
Priority to EP93914854A priority patent/EP0650355A1/en
Priority to JP6503078A priority patent/JPH07508530A/en
Priority to AU45076/93A priority patent/AU4507693A/en
Priority to PCT/GB1993/001377 priority patent/WO1994001095A2/en
Priority to CA002139440A priority patent/CA2139440A1/en
Priority to KR1019940704887A priority patent/KR950702112A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB929214184A 1992-07-03 1992-07-03 Pharmaceuticals Pending GB9214184D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB929214184A GB9214184D0 (en) 1992-07-03 1992-07-03 Pharmaceuticals
EP93914854A EP0650355A1 (en) 1992-07-03 1993-06-30 Medicaments for the treatment of visceral pain and migraine
JP6503078A JPH07508530A (en) 1992-07-03 1993-06-30 Medicines for treating visceral pain and migraines
AU45076/93A AU4507693A (en) 1992-07-03 1993-06-30 Medicaments for the treatment of visceral pain and migraine
PCT/GB1993/001377 WO1994001095A2 (en) 1992-07-03 1993-06-30 Medicaments for the treatment of visceral pain and migraine
CA002139440A CA2139440A1 (en) 1992-07-03 1993-06-30 Medicaments for the treatment of visceral pain and migraine
KR1019940704887A KR950702112A (en) 1992-07-03 1994-12-31 Medicines for the treatment of visceral pain and migraine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214184A GB9214184D0 (en) 1992-07-03 1992-07-03 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9214184D0 true GB9214184D0 (en) 1992-08-12

Family

ID=10718169

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929214184A Pending GB9214184D0 (en) 1992-07-03 1992-07-03 Pharmaceuticals

Country Status (7)

Country Link
EP (1) EP0650355A1 (en)
JP (1) JPH07508530A (en)
KR (1) KR950702112A (en)
AU (1) AU4507693A (en)
CA (1) CA2139440A1 (en)
GB (1) GB9214184D0 (en)
WO (1) WO1994001095A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
EP0664794A1 (en) * 1992-10-16 1995-08-02 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
DE19807535A1 (en) * 1998-02-21 1999-08-26 Asta Medica Ag Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
EP1152761B1 (en) 1999-02-18 2009-06-24 Novasearch AG Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
TWI263496B (en) * 1999-12-10 2006-10-11 Novartis Ag Pharmaceutical combinations and their use in treating gastrointestinal disorders
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
ATE359079T1 (en) 2003-01-13 2007-05-15 Dynogen Pharmaceuticals Inc METHOD FOR TREATING NAUSEA, VOMITING, REGAGING, OR ANY COMBINATION THEREOF
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1908A (en) * 1984-12-20 1985-12-13 Sandoz Ag Treatment of gastrointestinal disorders using 5-HT3 antagonists
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
DE3782107T2 (en) * 1986-07-25 1993-04-01 Beecham Group Plc AZABICYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE.
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8806990D0 (en) * 1988-03-23 1988-04-27 Beecham Group Plc Novel compounds
GB8701022D0 (en) * 1987-01-19 1987-02-18 Beecham Group Plc Treatment
EP0287196B1 (en) * 1987-02-18 1994-11-23 Beecham Group Plc Indole derivatives, process for their preparation and pharmaceutical compositions containing them
EP0289170B1 (en) * 1987-04-25 1993-06-23 Beecham Group Plc Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
JPH01258673A (en) * 1987-10-22 1989-10-16 Glaxo Group Ltd Ketone derivative
ATE108791T1 (en) * 1987-11-04 1994-08-15 Beecham Group Plc NEW 4-OXOBENZOTRIAZINE AND 4-OXOCHINAZOLINE.
EP0336759A1 (en) * 1988-04-07 1989-10-11 Glaxo Group Limited Imidazole derivatives
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
IT1226389B (en) * 1988-07-12 1991-01-15 Angeli Inst Spa NEW AMIDID AND GUANIDINE DERIVATIVES
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
US5008272A (en) * 1988-08-15 1991-04-16 Glaxo Group Limited Lactam derivatives
GB8820650D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
US5173493A (en) * 1988-09-27 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Pyridoindole derivatives and processes for preparation thereof
GB8823980D0 (en) * 1988-10-13 1988-11-23 Glaxo Group Ltd Chemical compounds
GB8829079D0 (en) * 1988-12-13 1989-01-25 Beecham Group Plc Novel compounds
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
DE69028934T2 (en) * 1989-02-02 1997-03-20 Yamanouchi Pharma Co Ltd Tetrahydrobenzimidazole derivatives
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
EP0387431A1 (en) * 1989-03-14 1990-09-19 Beecham Group Plc Imidazole derivatives, process for their preparation and their pharmaceutical use
GB8916682D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Pharmaceutical compounds
DK443489D0 (en) * 1989-09-08 1989-09-08 Ferrosan As SUBSTITUTED URINARY COMPOUNDS, THEIR PREPARATION AND USE
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
US4992461A (en) * 1989-09-11 1991-02-12 G. D. Searle & Co. N-azabicyclo(3.3.0)octane amides of aromatic acids, compositions, and methods of use thereof
WO1991007402A1 (en) * 1989-11-17 1991-05-30 Pfizer Inc. Azabicyclo amides and esters as 5-ht3 receptor antagonists
DK40890D0 (en) * 1990-02-16 1990-02-16 Ferrosan As SUBSTITUTED URINARY COMPOUNDS, THEIR PREPARATION AND USE
JPH0648960A (en) * 1990-02-22 1994-02-22 Glaxo Group Ltd Medicine
US5140023A (en) * 1990-04-27 1992-08-18 G. D. Searle & Co. Azatetracycle compounds
GB9020927D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Pharmaceuticals
GB9027487D0 (en) * 1990-12-19 1991-02-06 Beecham Group Plc Pharmaceuticals
JPH06506443A (en) * 1991-01-09 1994-07-21 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Azabicyclic and azatricyclic derivatives, processes and intermediates thereof, and pharmaceutical compositions containing the compounds
GB9103839D0 (en) * 1991-02-23 1991-04-10 Smithkline Beecham Plc Pharmaceuticals
US5137893A (en) * 1991-03-07 1992-08-11 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
EP0554794B1 (en) * 1992-02-04 1998-07-29 Eisai Co., Ltd. Aminobenzoic acid derivatives

Also Published As

Publication number Publication date
CA2139440A1 (en) 1994-01-20
AU4507693A (en) 1994-01-31
WO1994001095A2 (en) 1994-01-20
KR950702112A (en) 1995-06-19
WO1994001095A3 (en) 1994-04-14
EP0650355A1 (en) 1995-05-03
JPH07508530A (en) 1995-09-21

Similar Documents

Publication Publication Date Title
AP9300494A0 (en) Pharmaceuticals
GB9221468D0 (en) Pharmaceuticals
GB9204565D0 (en) Pharmaceuticals
GB9219163D0 (en) Pharmaceuticals
GB9205917D0 (en) Pharmaceuticals
GB9214184D0 (en) Pharmaceuticals
GB9201961D0 (en) Pharmaceuticals
GB9220585D0 (en) Pharmaceuticals
GB9208321D0 (en) Pharmaceuticals
GB9211978D0 (en) Pharmaceuticals
GB9218846D0 (en) Pharmaceuticals
GB9205427D0 (en) Pharmaceuticals
GB9205428D0 (en) Pharmaceuticals
GB9205363D0 (en) Pharmaceuticals
GB9205918D0 (en) Pharmaceuticals
GB9206075D0 (en) Pharmaceuticals
GB9207414D0 (en) Pharmaceuticals
GB9207820D0 (en) Pharmaceuticals
GB9203977D0 (en) Pharmaceuticals
GB9208434D0 (en) Pharmaceuticals
GB9211072D0 (en) Pharmaceuticals
GB9211082D0 (en) Pharmaceuticals
GB9211925D0 (en) Pharmaceuticals
GB9211926D0 (en) Pharmaceuticals
GB9221442D0 (en) Pharmaceuticals